These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 8331861)

  • 1. [How I take charge and treat type II diabetes resistant to usual treatment].
    Ziegler O; Guerci B; Crea-Avila T; Candiloros H; Drouin P
    Journ Annu Diabetol Hotel Dieu; 1993; ():139-54. PubMed ID: 8331861
    [No Abstract]   [Full Text] [Related]  

  • 2. [High density lipoprotein cholesterol in obese non-insulin-dependent diabetic patients].
    Arteaga A; Velasco N; Maiz A; Villanueva C; Acosta AM
    Rev Med Chil; 1986 Jun; 114(6):509-15. PubMed ID: 3575945
    [No Abstract]   [Full Text] [Related]  

  • 3. [Changes in carbohydrate and lipid metabolism in obesity].
    Actis Dato SM; Pittana J; Costa Gil JE; Nieto RE
    Medicina (B Aires); 1986; 46(6):677-85. PubMed ID: 3306255
    [No Abstract]   [Full Text] [Related]  

  • 4. A simple measure of insulin resistance.
    Duncan MH; Singh BM; Wise PH; Carter G; Alaghband-Zadeh J
    Lancet; 1995 Jul; 346(8967):120-1. PubMed ID: 7603193
    [No Abstract]   [Full Text] [Related]  

  • 5. Correlation studies between concentrations of glycosylated haemoglobins and lipids in non-insulin-dependent Nigerian diabetics.
    Erasmus RT; Olukoga O; Adelowo O; Adewoye HO
    Cent Afr J Med; 1986 Oct; 32(10):231-6. PubMed ID: 3652181
    [No Abstract]   [Full Text] [Related]  

  • 6. Correction of hyperglycaemia reduces insulin resistance and serum soluble E-selectin levels in patients with Type 2 diabetes mellitus.
    Matsumoto K; Nakamura H; Ueki Y; Tominaga T; Miyake S
    Diabet Med; 2001 Mar; 18(3):224-8. PubMed ID: 11318844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved glycemic control increases fasting plasma acylation-stimulating protein and decreases leptin concentrations in type II diabetic subjects.
    Ozata M; Gungor D; Turan M; Ozisik G; Bingol N; Ozgurtas T; Ozdemir IC
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3659-64. PubMed ID: 11502793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adding metformin versus insulin dose increase in insulin-treated but poorly controlled Type 2 diabetes mellitus: an open-label randomized trial.
    Relimpio F; Pumar A; Losada F; Mangas MA; Acosta D; Astorga R
    Diabet Med; 1998 Dec; 15(12):997-1002. PubMed ID: 9868971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modification of therapy from insulin to chlorpropamide decreases HDL cholesterol in patients with non-insulin-dependent diabetes mellitus.
    Schmitt JK; Harriman K; Poole JR
    Diabetes Care; 1987; 10(6):692-6. PubMed ID: 3322724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased levels of HDL-cholesterol and apolipoprotein A-I after intensified insulin therapy for diabetes.
    Wilson DP; Fesmire JD; Endres RK; Blackett PR
    South Med J; 1985 Jun; 78(6):636-8. PubMed ID: 3923627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of short periods of caloric restriction on weight loss and glycemic control in type 2 diabetes.
    Williams KV; Mullen ML; Kelley DE; Wing RR
    Diabetes Care; 1998 Jan; 21(1):2-8. PubMed ID: 9538962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term treatment of type I diabetes in 28 patients using two different implantable programmable pumps.
    Jeandidier N; Pinget M; Keipes M; Louy S; Charton MN; Marescaux J; Reville P
    Transplant Proc; 1992 Jun; 24(3):940-1. PubMed ID: 1604674
    [No Abstract]   [Full Text] [Related]  

  • 13. Insulin secretion, insulin action, and hepatic glucose production in identical twins discordant for non-insulin-dependent diabetes mellitus.
    Vaag A; Henriksen JE; Madsbad S; Holm N; Beck-Nielsen H
    J Clin Invest; 1995 Feb; 95(2):690-8. PubMed ID: 7860750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of normalizing fasting glucose with bedtime NPH insulin alone in NIDDM.
    Cusi K; Cunningham GR; Comstock JP
    Diabetes Care; 1995 Jun; 18(6):843-51. PubMed ID: 7555511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of insulin on cholesterol synthesis in type II diabetes patients.
    Scoppola A; Testa G; Frontoni S; Maddaloni E; Gambardella S; Menzinger G; Lala A
    Diabetes Care; 1995 Oct; 18(10):1362-9. PubMed ID: 8721938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of newly diagnosed non-insulin-dependent (type 2) diabetes mellitus: a retrospective audit.
    Marsiaj HI; Catalano C; Sum CF; Home PD; Alberti KG
    Diabetes Res Clin Pract; 1991 May; 12(2):129-36. PubMed ID: 1879304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlations between glycosylated haemoglobin and other metabolic parameters in insulin-dependent diabetics.
    Odetti P; Ansaldi E; Diara C; Cheli V; Andraghetti G; Buzzo P; Prando R
    Diabete Metab; 1983 Mar; 9(1):26-31. PubMed ID: 6343150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum leptin and its relationship with metabolic variables in Arabs with type 2 diabetes mellitus.
    Al-Shoumer KA; Al-Asousi AA; Doi SA; Vasanthy BA
    Ann Saudi Med; 2008; 28(5):367-70. PubMed ID: 18779635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationships between HDL-C subfractions and HbA1C levels in non-insulin-dependent diabetics.
    Rodenas S; Cuesta C; Martini C; Sanchez-Cabezudo M
    Isr J Med Sci; 1993 Dec; 29(12):797-9. PubMed ID: 8300390
    [No Abstract]   [Full Text] [Related]  

  • 20. Prevalence of patients reaching the targets of good control in normal clinical practice. A cohort-based study in type 2 diabetes.
    Bo S; Cavallo-Perin P; Gentile L
    Diabetes Care; 1999 Dec; 22(12):2092. PubMed ID: 10587855
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.